MB07133 for the Treatment of Patients With Unresectable Hepatocellular Carcinoma

Conditions: Safety Issues; Effect of Drug; Tolerance Interventions: Drug: MB07133 Sponsors: Xi ' an Xintong Pharmaceutical Research Co.,Ltd.; The First Hospital of Jilin University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials